Delivery Order SPE2DB22D3501-SPE2DB24FWA76

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF5VR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.08 firm fixed-price delivery order is for the provision of PROTONIX 40 MG SUSPENSION 30S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025 and is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.77 firm fixed-price delivery order is for the supply of 4,566,894 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 13, 2025 and is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,561.57 contract is for Pantoprazole DR 40 mg suspension packets and has a firm fixed price. The award is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order for $1,024.75 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of pantoprazole sodium delayed-release tablets, a generic medication used to treat conditions such as gastroesophageal reflux disease. The contract was awarded by the Defense Logistics Agency (DLA), a combat support agency of the U.S. Department of Defense, and does not have a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,247.30, is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count containers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is a $1,593.72 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, a medication used to treat gastroesophageal reflux disease and other conditions. The contract is a firm fixed-price, non-set-aside award with a completion date of July 1, 2025....
This federal contract award, with a unique identifier of SPE2DB22D3009|SPE2DB25FAQ77, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,682.21, is a Firm Fixed Price Delivery Order for the supply of 4,567,198,187 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of February 7, 2025 and does not have a set-aside...
This federal contract award, valued at $1,870.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Protopam Chloride 1 GM vials, a medical product, with a period of performance through January 6, 2025. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an order value of $1,552.74. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of 450 tablets of Pantoprazole Sodium Delayed-Release 40 mg, a prescription medication. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables efficient...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWA76
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,729.37 firm fixed-price delivery order is for the supply of PROTONIX IV 40 MG VIALS, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contract portfolio and its role as a key vendor for various government healthcare programs, including the military and veterans' healthcare systems, demonstrate its significant capabilities in pharmaceutical and medical supply distribution.

Generated 5/17/25, 9:42 AM